Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes.

Chung HH, Moon JS, Yoon JS, Lee HW, Won KC.

Diabetes Metab J. 2013 Apr;37(2):125-31. doi: 10.4093/dmj.2013.37.2.125. Epub 2013 Apr 16.

PMID:
23641353
[PubMed]
Free PMC Article
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
3.

Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry.

Yang X, So WY, Ma RC, Kong AP, Xu G, Chan JC.

Diabetes Metab Res Rev. 2012 Jul;28(5):379-87. doi: 10.1002/dmrr.2287. Epub 2012 Feb 8. Review.

PMID:
22318884
[PubMed - indexed for MEDLINE]
4.

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.

Krentz AJ.

Diabetes Obes Metab. 2003 Nov;5 Suppl 1:S19-27. Review.

PMID:
14984018
[PubMed - indexed for MEDLINE]
5.

[Diabetes and cancer risk: oncologic considerations].

Rosta A.

Orv Hetil. 2011 Jul 17;152(29):1144-55. doi: 10.1556/OH.2011.29158. Review. Hungarian.

PMID:
21712179
[PubMed - indexed for MEDLINE]
6.

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.

PMID:
16259526
[PubMed - indexed for MEDLINE]
7.

Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.

Salpeter SR, Buckley NS, Kahn JA, Salpeter EE.

Am J Med. 2008 Feb;121(2):149-157.e2. doi: 10.1016/j.amjmed.2007.09.016. Review.

PMID:
18261504
[PubMed - indexed for MEDLINE]
8.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

PMID:
15147610
[PubMed - indexed for MEDLINE]
Free Article
9.

Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy.

Jafri H, Alsheikh-Ali AA, Karas RH.

J Am Coll Cardiol. 2010 Jun 22;55(25):2846-54. doi: 10.1016/j.jacc.2009.12.069. Review.

PMID:
20579542
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk